TEHRAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1934-01-01

Employees: 1K

Market Cap: -

Website: http://www.tums.ac.ir

Clinical Trials

Assessing an Educational Intervention Program on Knowledge, Attitude and Behaviour Towards Pregnancy Prevention Based on Health Belief Model Amongst Adolescent Girls in Northern Ghana

Not Applicable

Completed

Conditions: Adolescent Behavior

Interventions: Behavioral: comprehensive sex education

First Posted Date: 2017-12-27

Last Posted Date: 2018-11-06

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 363

Registration Number: NCT03384251

Locations: 🇬🇭
Kalpohin Senior High School, Tamale, Northern Region, Ghana
🇬🇭
Vittin Senoir High School, Tamale, Northern Region, Ghana

Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus

Phase 3

Completed

Conditions: Human Immunodeficiency Virus
Hepatitis C Virus Infection, Response to Therapy of

Interventions: Drug: sofosbuvir and daclatasvir

First Posted Date: 2017-12-12

Last Posted Date: 2019-02-20

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 232

Registration Number: NCT03369327

Locations: 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of
🇮🇷
Emam Hospital, Tehran, Iran, Islamic Republic of

Clinical Evaluation of the Effect of LANAP as an Adjunct Treatment in Management of Patients With Chronic Periodontitis

Not Applicable

Completed

Conditions: Periodontitis
Laser

Interventions: Radiation: LANAP off
Radiation: LANAP (Laser Assisted New Attachment Procedure)

First Posted Date: 2017-12-07

Last Posted Date: 2021-03-03

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT03365167

Locations: 🇮🇷
Neda Moslemi, Tehran, Iran, Islamic Republic of

Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women

Phase 3

Completed

Conditions: Osteopenia

Interventions: Drug: Oligopin
Drug: Placebo

First Posted Date: 2017-08-24

Last Posted Date: 2020-05-20

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 43

Registration Number: NCT03260803

Locations: 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus

Not Applicable

Completed

Conditions: Diabetes Mellitus Type II

Interventions: Dietary Supplement: EPA Placebo
Dietary Supplement: EPA Supplement

First Posted Date: 2017-08-23

Last Posted Date: 2017-08-23

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 36

Registration Number: NCT03258840

Locations: 🇮🇷
Tehran University of Medical Sciences (TUMS), School of Nutritional Sciences and Dietetics, Department of Cellular and Molecular Nutrition, Tehran, Iran, Islamic Republic of

Food Groups Associated With Anaemia in Pregnant Women

Completed

Conditions: Anemia
Dietary Habits
Food Habits

Interventions: Dietary Supplement: Food groups consumed

First Posted Date: 2017-08-16

Last Posted Date: 2017-08-22

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 592

Registration Number: NCT03251664

Locations: 🇪🇹
Addis Ababa Health Bureau, Addis Ababa, Ethiopia

Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction

Not Applicable

Conditions: Congenital Nasolacrimal Duct Obstruction

Interventions: Procedure: Endoscopy Assisted Probing procedure

First Posted Date: 2017-08-08

Last Posted Date: 2019-10-10

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 320

Registration Number: NCT03242681

Locations: 🇮🇷
Farzad Pakdel, Tehran, Iran, Islamic Republic of

Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients

Phase 4

Completed

Conditions: Hepatitis C

Interventions: Drug: sofosbuvir and daclatasvir

First Posted Date: 2017-06-27

Last Posted Date: 2019-02-15

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 1448

Registration Number: NCT03200184

Locations: 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Phase 3

Completed

Conditions: Uncontrolled Type 2 Diabetes Mellitus

Interventions: Drug: Sitagliptin 100mg
Drug: Pioglitazone 30 mg

First Posted Date: 2017-04-24

Last Posted Date: 2017-04-24

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 250

Registration Number: NCT03125694

Locations: 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

Phase 4

Completed

Conditions: Hepatitis C, Chronic
Chronic Renal Failure

Interventions: Drug: Sofosbuvir 400 mg and daclatasvir 60 mg

First Posted Date: 2017-02-24

Last Posted Date: 2019-09-30

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 95

Registration Number: NCT03063879

Locations: 🇮🇷
Shariati Hospital, Tehran, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy